Cargando…
Enhanced anticancer effect of oncostatin M combined with salinomycin in CD133(+) HepG2 liver cancer cells
Oncostatin M (OSM) induces the differentiation of liver cancer stem cells (LCSCs) and increases sensitivity to the chemotherapeutic agent 5-fluorouracil, whereas salinomycin (Sal) induces apoptosis in cancer stem cells and inhibits the proliferation of liver cancer cells. However, there have been no...
Autores principales: | Fu, Changhao, Wang, Lu, Tian, Geer, Zhang, Chen, Zhao, Yuanyuan, Xu, Hao, Su, Manman, Wang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341778/ https://www.ncbi.nlm.nih.gov/pubmed/30675240 http://dx.doi.org/10.3892/ol.2018.9796 |
Ejemplares similares
-
Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells
por: Jiang, Qin, et al.
Publicado: (2017) -
Primary Human Hepatocytes, But not HepG2 or Balb/c 3T3 Cells, Efficiently Metabolize Salinomycin and Are Resistant to Its Cytotoxicity
por: Radko, Lidia, et al.
Publicado: (2020) -
Anticancer Effects of Emodin on HepG2 Cell: Evidence from Bioinformatic Analysis
por: Zhou, Rui-sheng, et al.
Publicado: (2019) -
Preparation of β-CD-Ellagic Acid Microspheres and Their Effects on HepG2 Cell Proliferation
por: Wang, Hongkai, et al.
Publicado: (2017) -
Anticancer Effects of Bufalin on Human Hepatocellular Carcinoma HepG2 Cells: Roles of Apoptosis and Autophagy
por: Miao, Qing, et al.
Publicado: (2013)